FMR LLC raised its position in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) by 0.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,564,624 shares of the company's stock after purchasing an additional 90,862 shares during the period. FMR LLC owned approximately 15.00% of Owens & Minor worth $181,449,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of the stock. Quarry LP boosted its position in Owens & Minor by 290.1% during the 2nd quarter. Quarry LP now owns 2,099 shares of the company's stock valued at $28,000 after acquiring an additional 1,561 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $43,000 after buying an additional 1,356 shares during the period. Innealta Capital LLC bought a new position in shares of Owens & Minor during the 2nd quarter valued at about $43,000. Blue Trust Inc. boosted its holdings in shares of Owens & Minor by 176.8% during the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock valued at $44,000 after purchasing an additional 1,780 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Owens & Minor by 100.6% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company's stock valued at $82,000 after purchasing an additional 3,044 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company's stock.
Owens & Minor Price Performance
Shares of OMI traded up $0.08 during trading hours on Tuesday, reaching $14.18. The company had a trading volume of 214,907 shares, compared to its average volume of 816,070. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The company has a market capitalization of $1.09 billion, a price-to-earnings ratio of -21.68, a PEG ratio of 0.46 and a beta of 0.42. The firm has a 50 day simple moving average of $13.48 and a 200-day simple moving average of $14.93. Owens & Minor, Inc. has a 12-month low of $11.42 and a 12-month high of $28.35.
Owens & Minor (NYSE:OMI - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. During the same period in the previous year, the firm earned $0.44 earnings per share. Owens & Minor's revenue was up 5.0% compared to the same quarter last year. Research analysts expect that Owens & Minor, Inc. will post 1.49 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts recently weighed in on OMI shares. UBS Group reduced their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, November 5th. StockNews.com downgraded shares of Owens & Minor from a "buy" rating to a "hold" rating in a research note on Monday, August 26th. Barclays reduced their target price on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a report on Tuesday, November 5th. Citigroup cut their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a report on Tuesday, November 5th. Finally, Robert W. Baird cut their target price on shares of Owens & Minor from $19.00 to $14.00 and set a "neutral" rating for the company in a research note on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, Owens & Minor presently has an average rating of "Hold" and an average price target of $18.50.
Check Out Our Latest Analysis on OMI
Insiders Place Their Bets
In related news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now owns 130,822 shares in the company, valued at $1,546,316.04. This represents a 3.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 2.62% of the stock is owned by corporate insiders.
About Owens & Minor
(
Free Report)
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Featured Articles
Before you consider Owens & Minor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.
While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.